open access
Cancer patients and smoking cessation
, 1
Affiliations- Head of Smoking Cessation Unit, Cancer Epidemiology and Primary Prevention Deprtment, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
open access
Abstract
Abstinence from smoking is the most important element of cancer prevention. Tobacco smoking is responsible for at least 15 different cancer localization and almost 30% of all cancer deaths. There is evidence that not only smoking after cancer diagnosis brings negative effects for cancer treatment efficacy and tolerability, but also quitting smoking after cancer diagnosis has significant benefits. They include: increase survival rates and decrease overall mortality, decrease the risk of second primary cancer, decrease the risk of recurrence, increase the tolerability of oncological treatments and its efficacy, reduce pain. Quitting smoking improves the quality of life too. Nicotine dependence is not only the choice of patients and style of life but a chronic and relapsing disease. Failure to undertake treatment by the center's staff may be treated as malpractice. Various evidence-based treatment options are available and they can, or even should, be adapted to the specificity of oncological patients.
Abstract
Abstinence from smoking is the most important element of cancer prevention. Tobacco smoking is responsible for at least 15 different cancer localization and almost 30% of all cancer deaths. There is evidence that not only smoking after cancer diagnosis brings negative effects for cancer treatment efficacy and tolerability, but also quitting smoking after cancer diagnosis has significant benefits. They include: increase survival rates and decrease overall mortality, decrease the risk of second primary cancer, decrease the risk of recurrence, increase the tolerability of oncological treatments and its efficacy, reduce pain. Quitting smoking improves the quality of life too. Nicotine dependence is not only the choice of patients and style of life but a chronic and relapsing disease. Failure to undertake treatment by the center's staff may be treated as malpractice. Various evidence-based treatment options are available and they can, or even should, be adapted to the specificity of oncological patients.
Keywords
cancer prevention; nicotine dependence; tobacco smoking; smoking cessation; cancer patients
About this articleTitle
Cancer patients and smoking cessation
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Review paper
Published online
2023-11-20
Page views
23
Article views/downloads
17
Keywords
cancer prevention
nicotine dependence
tobacco smoking
smoking cessation
cancer patients
Authors
Magdalena Cedzyńska
Irena Anna Przepiorka
References (44)- Peto R, Lopez AD, Boreham J, et al. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992; 339(8804): 1268–1278.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke and Involuntary Smoking. International Agency for Research on Cancer, Lyon 2004: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 83.
- Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004; 45 Suppl 2: S3–S9.
- Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003; 123(1 Suppl): 21S–49S.
- https://gco.iarc.fr/.
- Wojciechowska U, Barańska K, Michałek I, et al. Nowotwory złośliwe w Polsce w 2020 roku. Cancer in Poland in 2020. https://onkologia.org.pl/sites/default/files/publications/2023-01/nowotwory_2020.pdf.
- http://monographs.iarc.fr/ENG/Monographs/vol83/mono83.pdf.
- Mańczuk M, Sulkowska U, Łobaszewski J, et al. Time trends in tobacco-attributable cancer mortality in Poland — direct estimation method. Nowotwory. Journal of Oncology. 2017; 67(4): 227–235.
- https://www.who.int/news-room/fact-sheets/detail/tobacco.
- Warren GW, Kasza KA, Reid ME, et al. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013; 132(2): 401–410.
- Jassem J. Tobacco smoking after diagnosis of cancer: clinical aspects. Transl Lung Cancer Res. 2019; 8(Suppl 1): S50–S58.
- Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993; 328(3): 159–163.
- Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010; 340: b5569.
- Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003; 76(4): 1001–7; discussion 1007.
- Ford MB, Sigurdson AJ, Petrulis ES, et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003; 98(7): 1457–1464.
- Rugg T, Saunders MI, Dische S. Smoking and mucosal reactions to radiotherapy. Br J Radiol. 1990; 63(751): 554–556.
- Moreira DM, Aronson WJ, Terris MK, et al. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database. Cancer. 2014; 120(2): 197–204.
- Petros WP, Younis IR, Ford JN, et al. Effects of tobacco smoking and nicotine on cancer treatment. Pharmacotherapy. 2012; 32(10): 920–931.
- Warren GW, Sobus S, Gritz ER. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. Lancet Oncol. 2014; 15(12): e568–e580.
- Alsadius D, Hedelin M, Johansson KA, et al. Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer. Radiother Oncol. 2011; 101(3): 495–501.
- Sørensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012; 147(4): 373–383.
- Schmid M, Sood A, Campbell L, et al. Impact of smoking on perioperative outcomes after major surgery. Am J Surg. 2015; 210(2): 221–229.e6.
- Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004; 126(6): 1733–1741.
- Duffy SA, Terrell JE, Valenstein M, et al. Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patients. Gen Hosp Psychiatry. 2002; 24(3): 140–147.
- Gritz ER, Carmack CL, de Moor C, et al. First year after head and neck cancer: quality of life. J Clin Oncol. 1999; 17(1): 352–360.
- U.S. Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General—Executive Summary. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA 2020.
- Carson K, Usmani Z, Robertson T, et al. Smoking cessation interventions for lung cancer patients. Lung Cancer Management. 2013; 2(1): 61–74.
- Daniel M, Keefe FJ, Lyna P, et al. Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain. 2009; 10(3): 323–328.
- Stapleton J. Cigarette smoking prevalence, cessation and relapse. Stat Methods Med Res. 1998; 7(2): 187–203.
- Boyle P. Tobacco: science , policy and public health. Oxford University Press 2004.
- Kleinjan M, Engels RC, van Leeuwe J, et al. Mechanisms of adolescent smoking cessation: roles of readiness to quit, nicotine dependence, and smoking of parents and peers. Drug Alcohol Depend. 2009; 99(1-3): 204–214.
- Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008(1): CD000146.
- Theodoulou A, Chepkin SC, Ye W, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2023; 6(6): CD013308.
- Hajizadeh A, Howes S, Theodoulou A, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2023; 5(5): CD000031.
- Correa-Morales JE, Cuellar-Valencia L, Mantilla-Manosalva N, et al. Cancer and Non-cancer Fatigue Treated With Bupropion: A Systematic Review. J Pain Symptom Manage. 2023; 65(1): e21–e28.
- Shields PG, Bierut L, Arenberg D, et al. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023; 21(3): 297–322.
- Livingstone-Banks J, Fanshawe T, Thomas K, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews. 2023; 2023(6).
- https://tosieleczy.pl/wp-content/uploads/2022/05/Raport-FWZ-TSL_stygmatyzacja-pacjentow-z-RP_310522.pdf.
- Cordova M, Giese-Davis J, Golant M, et al. Breast Cancer as Trauma: Posttraumatic Stress and Posttraumatic Growth. Journal of Clinical Psychology in Medical Settings. 2007; 14(4): 308–319.
- Domanowska G, Greszta E, Ćwiklińska-Zaborowicz A. Odkrywanie wartości życia w chorobie nowotworowej. Kwartalnik Naukowy Fides Et Ratio. 2018; 33(1): 202–218.
- https://tosieleczy.pl/wp-content/uploads/2023/05/Raport-Problem-palenia-wsrod-pacjentow-300523.pdf.
- Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013; 2013(5): CD000165.
- Aveyard P, Begh R, Parsons A, et al. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012; 107(6): 1066–1073.
- Vidrine JI, Shete S, Cao Y, et al. Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med. 2013; 173(6): 458–464.